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276Objective: Patients with bicuspid aortic valves can present with aortic insufficiency caused by cusp disease or the
aortic root pathology. We present our 13-year experience with a functional and systematic approach to bicuspid
aortic valve repair.
Methods: Between 1995 and 2008, 122 consecutive patients (mean age, 44  11 years) with bicuspid aortic
valves underwent non-emergency valve repair for isolated aortic insufficiency (43%), aortic root dilatation
(14%), or both (43%). Preoperative echocardiography identified aortic dilatation (n ¼ 75), cusp prolapse
(n ¼ 96), and cusp restriction (n ¼ 45) as mechanisms of aortic insufficiency. Raphe´ repair (n ¼ 98) was per-
formed by shaving (21%) or resection with primary closure (60%) or pericardial patch (18%). Functional aortic
annuloplasty was performed using subcommissural annuloplasty (n ¼ 51), ascending aortic replacement
(n ¼ 17), or aortic root replacement (n ¼ 54) using a reimplantation (76%) or remodeling technique (24%).
Results: There was no operative mortality. Five patients underwent early aortic valve reoperation (3 re-repairs).
At discharge, 93% of patients had aortic insufficiency grade 0/1 and 7% of patients had grade 2. Seven additional
patients underwent aortic valve reoperation during follow-up (2 re-repairs). Overall survival was 97% 3% at 8
years. At 5 and 8 years follow-up, freedom from aortic valve reoperation was 94%  2% and 83%  5%, re-
spectively, and freedom from aortic valve replacement was 96%  2% and 90%  5%, respectively. Freedom
from recurrent aortic insufficiency (>2þ) was 94% 3% at 5 years. Freedom from thromboembolism and bleed-
ing was 96%  2% at 8 years.
Conclusion: A systematic approach to bicuspid aortic valve repair yields good early and midterm results. Repair
of bicuspid valves for aortic insufficiency is a feasible and attractive alternative to mechanical valve replacement
in young patients. (J Thorac Cardiovasc Surg 2010;140:276-84)Supplemental material is available online.Bicuspid aortic valves (BAVs) are present in 1% to 2% of
the population. Longitudinal studies of patients with this
valvular abnormality have demonstrated that they have
equivalent survival compared with the general population.
However, a large proportion of them require surgical inter-
vention because of disease of the valve or ascending aorta.1,2
These patients often present in the third, fourth, or fifth
decade with their valvular disease and thus are likely to
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The Journal of Thoracic and Cardiovascular Surgthe choice of surgical intervention difficult because of the
limitations of currently available valve substitutes. Biopros-
thetic valves have a high structural failure rate in young pa-
tients (up to 4%/year) requiring multiple re-replacements.3
Mechanical valves have an excellent freedom from reopera-
tion, but risks of thromboembolic events (1%–2%/year)
and anticoagulation-related hemorrhage (2%/year) can
carry a significant burden because of the long exposure
time.4 The Ross operation is ideal for young patients with
BAV stenosis because of its durability, excellent patient sur-
vival, and low risk of thromboembolic complications.5
However, the presence of aortic insufficiency (AI) and aortic
root dilatation are important risk factors for pulmonary auto-
graft failure.6,7 For all of these reasons, repair of BAVs is an
attractive therapeutic option.
Despite numerous attempts at the systematic repair of re-
gurgitant BAVs, there are many questions that remain unan-
swered. First and most important is whether these valves
should be repaired at all. Limited data exist regarding
long-term follow-up and valve-related events, and there is
little available information that compares valve repair with
replacement. Second, what should be the criteria for ascend-
ing aortic replacement in these patients who have clearly
been demonstrated to have associated aortic abnormalities
at the morphologic, histologic, and molecular levels?8-10
Third, what is the ideal method for root and annularery c August 2010
TABLE 1. Preoperative patient characteristics
Variable N ¼ 122
Age (y, mean  SD) 44  11
Male gender (%) 113 (92)
NYHA class
I 38 (31)
II 66 (54)
III 15 (13)
Previous cardiac surgery (%) 5 (4)
LV ejection fraction<50% 11 (9)
LV end-systolic diameter (mm, mean  SD) 40  8
LV end-diastolic diameter (mm, mean  SD) 61  8
AI grade (%)
0 or I 17 (14)
II 22 (18)
III or IV 83 (68)
Aortic diameter (mm, mean  SD) 54  8
Abbreviations and Acronyms
AI ¼ aortic insufficiency
AV ¼ aortic valve
BAV ¼ bicuspid aortic valve
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Dstabilization? Fourth, how should the median raphe´ be man-
aged? And last, should a pericardial patch be used for cusp
augmentation?
This article describes our 13-year experience with BAV
repair with a focus on important anatomic features, our sur-
gical approach and techniques, early and midterm clinical
and echocardiographic outcomes, a critical analysis of repair
failures, and some answers to the questions posed above.Indication for surgery
AI only 52 (43)
Aortic dilatation only 17 (14)
Insufficiency and dilatation 53 (43)
NYHA, New York Heart Association; LV, left ventricular; SD, standard deviation;
AI, aortic insufficiency.MATERIALS AND METHODS
This study was approved by the ethics review board of the hospital, and
written informed consent was waived for this study.
Patient Population
Between December 1995 and September 2008, 122 consecutive patients
with BAVs underwent surgery for valve insufficiency or dilatation of the
proximal ascending aorta. Although the overall approach to the classifica-
tion and treatment of AI was guided by our previous study,11 specific fea-
tures of bicuspid valves were treated as described below. Preoperative
characteristics are described in Table 1. Data on surgical techniques were
collected prospectively and analyzed retrospectively.
Anatomic Features of Bicuspid Valves
BAV disease affects not only the valve cusps but also the functional aor-
tic annulus, comprising the ventriculoaortic junction, sinuses of Valsalva,
sinotubular junction, and tubular ascending aorta.9 We have adapted the
classification system proposed by Sievers and Schmidtke12 to aid in the de-
scription of cusp anatomy as it relates to valve repair. BAVs may be divided
into 2 general types (Figure 1). Type 0 BAVs do not contain a median raphe
and have 2 symmetric aortic sinuses, 2 commissures, and a symmetric base
of leaflet implantation of the 2 cusps. This configuration is present in a mi-
nority of cases. The mechanism of AI in this setting is usually cusp prolapse
of 1 or both cusps because of the presence of excess cusp tissue.
Type 1 BAVs, which are significantly more prevalent, have a median ra-
phe´ on the conjoint cusp and an asymmetric distribution of the aortic sinuses
with a large aortic sinus accompanying a large nonconjoint cusp and 2
smaller cusps fused together with a median raphe´. The raphe´ often attaches
to the cusp base in the form of a ‘‘pseudo-commissure,’’ which has a height
lower than that of the true commissures. The raphe´ may be restrictive,
fibrotic, calcified, or prolapsing. Furthermore, the base of leaflet implantation
is typically larger (ie, occupying a greater proportion of valve circumference)
and higher on the conjoint cusp compared with the nonconjoint cusp. The
mechanisms of AI in type 1 valves can be due to a rigid and restrictive raphe
associated with small fused cusps resulting in a triangular coaptation defect.
Alternatively, the raphe may be short and nonrestrictive with well-developed
cusps and associated prolapse of the conjoint cusp. Although BAVs have
classically been described as being type 0 or 1, we have observed that
they can be anywhere along a spectrum between type 0 and type 1.
Echocardiographic Evaluation
Preoperative or intraoperative transesophageal echocardiography was
routinely performed, focusing on the cusp anatomy (type 0 or 1), mecha-The Journal of Thoracic and Canism of AI, type (eccentric vs central), origin (cusp center or along entire
cusp free margin) and direction of AI jet, and measurement of components
of the aortic annulus (ventriculoaortic junction and sinotubular junction)
and the ascending aorta.
Surgical Techniques
Exposure and valve inspection. After median sternotomy and
institution of cardiopulmonary bypass and cardioplegia, a transverse aortot-
omy was performed approximately 1 cm above the sinotubular junction and
4-0 polypropylene sutures were placed at the level of the commissures for
exposure. With axial traction (perpendicular to the annular place) applied
on the commissural traction sutures, the aortic valve (AV) was assessed
for the mechanisms of AI and the echocardiographic findings were corrob-
orated. Valve assessment specifically focused on cusp anatomy (type 0 vs
type 1), the quantity and quality of cusp tissue available, and the presence
and location of calcium. The aortic root was inspected for size and the qual-
ity of aortic wall tissue.
Cusp repair. The aim of the cusp repair was to restore an adequate sur-
face of coaptation. In type 0 valves, the degree of prolapse was assessed by
comparing the prolapsing cusp with the nonprolapsing (reference) cusp. In
the case where both cusps were prolapsing, the goal was to restore the height
of coaptation to the midpoint of the sinuses of Valsalva. This was performed
using free margin plication, free margin resuspension with 7-0 polytetra-
fluoroethylene suture, or both as previously described.13 Thickened, fibrotic
areas of the leaflet (typically central aspect of the free margin) were shaved,
and localized decalcification was performed if calcium was present.
In type 1 valves, the median raphe´ was addressed first. If the raphe´ was
relatively mobile and only mildly thickened and fibrosed, it was preserved
and shaved. If the raphe´ was restrictive or calcified, a parsimonious triangu-
lar resection of this tissue was performed. Next, the quantity of cusp tissue
was assessed by putting the 2 arms of a 6-0 polypropylene suture on the free
margin of the conjoint cusp, on either side of the resected raphe´ (Figure E1,
A). At this point, lack of cusp restriction and good valve opening were signs
of the presence of adequate cusp tissue. The leaflet edges were reapproxi-
mated primarily when adequate cusp tissue was present using running
locked or interrupted 6-0 polypropylene sutures (Figure E1, B). In therdiovascular Surgery c Volume 140, Number 2 277
FIGURE 1. Variations in BAV cusp anatomy. A, Type 0 valve with symmetric cusps and aortic sinuses and no median raphe´. B, Type 1 asymmetric valve
with a median raphe´, well-developed cusps, excess cusp tissue, and prolapse of the conjoint cusp. C, Type 1 asymmetric valve with a restrictive raphe´ and
central triangular coaptation defect.
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dial patch was used for cusp restoration (Figure E1, C). Next, the free mar-
gins of both cusps were compared for the presence of any prolapse, which
was corrected using free-margin plication or resuspension with polytetra-
fluoroethylene (Figure E1, D). Raphe´ and cusp repair techniques used in
this cohort are depicted in Table 2.
Functional Aortic Annulus and Root Management
Intervention on the functional aortic annulus was performed systemati-
cally in all patients. In patients with a dilated aortic root (>4.5 cm), the aortic
root was replaced preferentially using the reimplantation technique as pre-
viously described. In patients with aortic root dimensions less than 4.5
cm, the quality of the aortic wall tissue was carefully assessed. Not infre-
quently, the aortic wall tissue was fragile and translucent with left ventric-
ular muscle visible through the aortic wall. In other cases, effacement of the
sinotubular junction or distal migration of the coronary ostia was observed.
In such cases, the aortic root was replaced. Last, in cases where the root was
not significantly dilated and the quality of aortic tissue was acceptable,
subcommissuroplasty was performed at the 2 commissures as previously
described.
Aortic root replacement using the reimplantation technique was the pre-
ferred method of root replacement and performed as previously described.14
In type 0 BAVs with symmetric cusps and sinuses, this symmetry was re-
spected while performing the proximal suture line, prosthesis preparation,
and valve reimplantation. In type 1 BAVs with a restrictive raphe and a def-
icit of cusp tissue on the conjoint cusp, the length of base of leaflet implan-
tation was reduced by making the prosthesis symmetric (even though the
natural distribution between the conjoint cusp to nonconjoint cusp was
55% to 45%). This reduction in the base of leaflet implantation provides
additional cusp tissue and can help avoid the need for cusp augmentation
with pericardium and in some cases may even induce prolapse that then re-
quires correction. A second important variation relates to the height of reim-
plantation of the pseudo-commissure. Implanting at the level of the cusp
base can result in lowering the height of the conjoint cusp, which then re-
quires extension with a pericardial patch, whereas implantation at the level
of the 2 normal commissures can cause cusp restriction and impair valve
opening. Thus, the natural height of the pseudo-commissure was usually re-
spected when reimplanting the valve unless specific alterations to the cusp278 The Journal of Thoracic and Cardiovascular Surggeometry were desired. Table 2 describes the aortic root and annular inter-
ventions in this cohort.
Postrepair Echocardiography
After repair, transesophageal echocardiography was performed in all pa-
tients to assess the degree of AI, orientation of the regurgitant jet (if present),
coaptation length, and coaptation height of the AV cusps. Coaptation length
of at least 5 mm at the midportion of the free margin and a coaptation height
above the AV annulus were prerequisites for a successful repair, and the
presence of an eccentric residual AI jet was an indication for reexploration
of the AV.15
Follow-up
Clinical follow-up was conducted through outpatient visits or telephone
follow-up by a research nurse. Information on survival status and valve-
related complications, including thromboembolism, hemorrhage,
endocarditis, reoperation, and cardiovascular symptoms, was obtained.
Transthoracic echocardiography was obtained in all patients predischarge
and at regular intervals during follow-up. The closing interval for the study
was between February 2009 and April 2009.
Statistical Analysis
Valve-related outcomes were defined as per published guidelines.16
Continuous data are presented as mean  standard deviation or median
(interquartile range) for nonparametric data. Failure time data on survival,
reoperation, and recurrent AI are presented using Kaplan–Meier survival
curves. Comparisons between groups for failure time data were performed
using log-rank test. Statistical analyses were performed using SAS v. 9.1
(SAS Institute, Cary, NC). Graphs were constructed using GraphPad Prism
5.0 (San Diego, Calif).
RESULTS
Early Outcome
A second cardiopulmonary bypass run was necessary in 4
patients (3%) because of residual AI. Postrepair intraopera-
tive transesophageal echocardiography demonstrated AIery c August 2010
TABLE 2. Intraoperative and postoperative data
Intraoperative data (n ¼ 122)
Concomitant procedures 16 (13)
Mitral valve repair 7 (6)
Aortic arch replacement 3 (2)
Coronary artery bypass 5 (4)
Ventricular septal defect closure 1 (0.8)
Cardiopulmonary bypass time (min, mean  SD) 106  39
Cardiac ischemia time (min, mean  SD) 86  34
BAV anatomy
Type 0 24 (20)
Type I 98 (80)
Raphe´ repair techniques (n ¼ 98)
Shaving (no resection) 21 (17)
Resection with direct reapproximation 59 (48)
Resection with pericardial patch 18 (15)
Cusp prolapse repair techniques (n ¼ 80)
Free margin plication 23 (19)
Free margin resuspension (PTFE) 72 (59)
Aortic root and ascending aortic procedures
Aortic root replacement 54 (44)
Reimplantation technique 41 (34)
Remodeling technique (partial) 10 (8)
Remodeling technique (complete) 3 (2)
Ascending aortic replacement 17 (14)
Subcommissural annuloplasty 51 (42)
Postrepair intraoperative TEE
AI grade 0 92 (75)
AI grade I 29 (24)
Postoperative outcomes
Mortality 0
Stroke 1 (0.8)
Reopening for bleeding 6 (5)
AV reintervention 5 (4)
Permanent pacemaker insertion 4 (3)
Predischarge echocardiography (n ¼ 119)
AI grade 0 59 (50)
AI grade I 51 (43)
AI grade II 9 (7)
PTFE, Polytetrafluoroethylene; TEE, transesophageal echocardiography; AV, aortic
valve; AI, aortic insufficiency; SD, standard deviation.
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There was no in-hospital mortality. Postoperative complica-
tions are listed in Table 2. Five patients underwent AV reop-
eration during the index admission, of whom 3 presented
relatively early in our experience (patient numbers 6, 8,
and 9). Two patients presented with dehiscence of direct su-
ture repair of a resected raphe´ and perforation, respectively,
and 1 patient presented with an aorta–right ventricle fistula
after a subcommissural annuloplasty. These 3 patients un-
derwent re-repair. Two other patients presented with resid-
ual AI and underwent a Ross procedure. The details of all
the AV reoperations are presented in Table E1. Predischarge
echocardiography was available in 98% of patients and
demonstrated AI grade 0 or 1 in 93% and AI grade 2 in 7%.The Journal of Thoracic and CaClinical Follow-up
Clinical follow-up was complete in 100% of patients with
a mean follow-up time of 61  38 months (620 patient-
years). Four patients died during follow-up. Two of these
deaths were cardiac related (1 occurred after coronary
surgery with a normally functioning AV), whereas the cause
of death was unknown in the other 2 deaths. Overall survival
was 97%  2% at 8 years (Figure 2, A).
Seven AV reoperations occurred during the follow-up
period at a mean follow-up time of 65 30 months for valve
stenosis (n ¼ 1), endocarditis (n ¼ 1), and recurrent AI
(n ¼ 5). Overall freedom from AV reoperation was 94%
 2% at 5 years and 83%  5% at 8 years (Figure 2, B).
Freedom from late AV reoperation (excluding the 5 early
AV reinterventions) was 98%  2% at 5 years and 87%
 5% at 8 years. Two of these patients underwent re-repair,
giving a overall freedom from AV replacement of 96% 
2% and 90%  5% at 5 and 8 years, respectively. The
details of the reoperations are listed in Table E1.
Four embolic events (1 transient ischemic attack, 3 strokes)
and no bleeding events occurred during the follow-up period,
giving a linearized rate of 0.6% per patient-year and a free-
dom from thromboembolic and bleeding complications of
96%  2% at 8 years. Two patients had endocarditis, 1 of
whom underwent AV re-repair as described above and 1 of
whom was treated medically. At last follow-up, 85% of pa-
tients were asymptomatic, 14% had New York Heart Associ-
ation II symptoms, and 1% had New York Heart Association
III symptoms.
Echocardiographic Follow-up
Echocardiographic follow-up was complete in 96% of pa-
tients with a mean follow-up time of 52 35 months. A total
of 11 patients presented with AI greater than 2þ, giving a free-
dom from significant recurrent AI of 94%  3% at 5 years.
Onepatient presentedwith severe aortic stenosisduring the fol-
low-up period and underwent valve replacement as described
above. Four additional patients presented with a mean valve
gradient between 25 and 35 mm Hg, and all were asymptom-
atic except 1 patient (New York Heart Association class II).
Subgroup Analyses
Patients undergoing a root replacement procedure (either
remodeling or reimplantation technique) had greater freedom
from recurrent AI (2þ) compared with those undergoing
subcommissural annuloplasty or supracoronary aortic re-
placement for root stabilization (freedom from recurrent AI:
95%  5% vs 80%  6% at 5 years, P¼ .03, Figure 2, C).
Whether or not a pericardial patch should be used for cusp
restoration after raphe´ resection remains controversial. Of 98
patients undergoing repair of a raphe´, 19 patients had a pericar-
dial patch used for cusp restoration. Use of a pericardial patch-
was associatedwith lower freedom from recurrent AI (80%
11% vs 85%  5% at 5 years, P ¼ .02, Figure 2, D). Cusprdiovascular Surgery c Volume 140, Number 2 279
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FIGURE 2. Clinical and echocardiographic outcomes after BAV repair. A, At 5 years, overall survival was 97%  2%. B, Freedom from AV reoperation
and replacement was 94% 2% and 96% 2% at 5 years, respectively. C, Patients undergoing aortic root replacement have a significantly lower recurrence
of AI compared with those undergoing subcommissural annuloplasty with or without aortic root replacement (*P¼ .03). D, In patients requiring raphe´ repair,
use of a patch was associated with greater recurrence of AI (**P ¼ .02). AV, Aortic valve; SCA, subcommissural annuloplasty; AA, ascending aorta.
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Danatomy (type 0 vs type 1) was not predictive of AI recur-
rence (P ¼ .93).
DISCUSSION
During the past 13 years, we have developed a systematic
approach to BAV repair that addresses both cusp and as-
cending aortic pathology and is tailored to the specific anat-
omy encountered. In 122 consecutive patients, we have
demonstrated that BAV repair is feasible and can be per-
formed safely. These patients continue to have excellent
long-term survival (97% at 8 years). Durability of the repair
remains acceptable at midterm follow-up with freedom
from late AV reoperation of 98% at 5 years and 87% at
8 years and freedom from recurrent AI (>2þ) of 94% at
5 years. Freedom from thromboembolic and bleeding com-
plications is excellent at 96% at 8 years. Analysis of the ef-
fect of surgical techniques on repair durability reveals that
aortic root replacement is associated with less AI recurrence
compared with subcommissural annuloplasty with or
without ascending aortic replacement, and the use of a peri-
cardial patch for raphe´ repair is associated with increased
recurrent AI.
Despite attempts by several groups to repair regurgitant
BAVs,17-20 these repair techniques remain infrequently
and heterogeneously applied. There are several possible rea-
sons for this. First, the complex interaction between the
valve cusp geometry and the functional aortic annulus that
results in a competent AV is not well understood. Second,
valve replacement with or without root replacement, not-280 The Journal of Thoracic and Cardiovascular Surgwithstanding its limitations in this young population, is tech-
nically simpler to perform and produces reproducible results
that are applicable to all patients.21 Third, and most impor-
tant, there is limited and inconsistent information about the
long-term outcomes of reparative procedures. Last, there is
a lack of uniformity in the techniques being applied for
BAV repair with important differences among different sur-
geons that causes some confusion and controversy regarding
the approach to valve repair.
One principle that has emerged as a commonality is that
BAV repair needs to address disease of the cusp and the
functional aortic annulus and ascending aorta. Root replace-
ment in this setting is performed not only to prevent the po-
tentially fatal complications of aortic dissection and rupture
but also to stabilize the repair procedure. Ongoing dilatation
of the ventriculoaortic junction or the sinotubular junction
can induce recurrent AI and render the cusp repair ineffec-
tive over the long term. Thus, if a BAV repair is to be attemp-
ted, an aggressive stance should be taken toward root
replacement. The threshold for root replacement can there-
fore be different depending on whether the valve is to be re-
paired or replaced. In our series, the decision to replace the
aortic root was based on size criteria and a visual assessment
of the quality of tissue of the aortic wall. All patients with
aortic root size greater than 4.5 cm and some patients with
aortic root diameter less than 4.5 cm with fragile aortic
wall tissue underwent root replacement. A similarly aggres-
sive stance has been advocated in patients undergoing BAV
replacement.21 Despite this aggressive stance, a rootery c August 2010
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FIGURE 3. Systematic approach to the repair of aortic root and cusp pathology in regurgitant BAVs.
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the development of recurrent AI in our series.
Another area of controversy relates to the use of a pericar-
dial patch for valve repair. In the pediatric population, a peri-
cardial patch is often necessary to reconstruct a commissure
or extend a leaflet that has been damaged or destroyed by
a previous balloon valvuloplasty procedure.22 In the adult
patient, however, a patch may be used for 2 reasons. The first
is for cusp restoration after the resection of a restrictive or
calcified raphe, as was done in our series. A second option
is to perform pericardial cusp extension to help increase
the coaptation surface of the conjoint cusp by adding tissue
to its free margin.23 Although good short-term results have
been reported with the latter approach, few data are available
about mid- and long-term outcomes.24 In our series, the use
of a pericardial patch was a risk factor for recurrent AI.
Possible reasons for this finding may be that the pericardium
becomes fibrotic or calcified with time, which leads to insuf-
ficiency, or that the use of a patch is typically necessary in
valves with a severely restrictive conjoint cusp that are
more difficult to repair and are thus at greater risk for failure.
Our approach to BAV repair can be applied in a systematic
manner to all patients presenting with isolated BAV insuffi-
ciency with or without aortic pathology (Figure 3). This ap-
proach relies on the understanding of the anatomic variations
of bicuspid valves with their associated mechanisms of
insufficiency. The first important question in this approach
is whether the aortic root requires replacement. Both aortic
root diameter and tissue quality are used to make this deci-
sion, and root replacement using the reimplantation tech-
nique is preferred when indicated. Next, cusp anatomy is
evaluated. In a symmetric (type 0) valve, the cusp repair in-
volves correction of leaflet prolapse by exclusion with orThe Journal of Thoracic and Cawithout resection of excess cusp tissue along the free mar-
gin. This maneuver elevates the free margin, increases the
coaptation height, and corrects the cusp prolapse. The tissue
that needs to be excluded is often the thickened central por-
tion of the leaflet. After the free margin plication (with or
without resection), additional elevation of the cusp free
margin can be achieved by resuspension with polytetra-
fluoroethylene suture. The objective is to have uniform co-
aptation of both cusps at approximately the midheight of
the sinuses of Valsalva. In type 1 valves, the tissue quality
of the conjoint cusp and the raphe´ are evaluated first. A re-
strictive and calcified raphe´ is treated with a parsimonious
restriction, whereas a raphe´ that is prolapsing, mildly
fibrotic, and accompanied by enough cusp tissue may be pre-
served and excluded with shaving and thinning of the tissue.
Next, the adequacy of cusp tissue on the conjoint cusp is as-
sessed. A type 1 prolapsing valve (Figure 1, B) typically has
sufficient tissue, whereas a type 1 (restrictive) valve will of-
ten require addition of a pericardial patch. Next, the free
margins of the 2 cusps are compared, and any residual or in-
duced prolapse is corrected as described above for type
0 valves. Technical adjuncts for aortic root replacement in
type 1 valves are used as described in the ‘‘Materials and
Methods’’ section.
Important lessons have been learned from the early and
late AV reoperations. Two early reoperations were for suture
dehiscence after direct reapproximation in a raphe´ repair. In
these cases, a tension-free repair is critical and the addition
of a pericardial patch can facilitate that. Furthermore, during
a root replacement with the reimplantation technique, the
base of implantation of the conjoint cusp can be reduced,
which increases the amount of cusp tissue available for co-
aptation. Another early AV reoperation was for a fistulardiovascular Surgery c Volume 140, Number 2 281
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the membranous septum while performing subcommissural
annuloplasty. Subcommissural annuloplasty in this region is
thus performed at a higher level to avoid this complication. It
can be performed lower in the fibrous portion of the suban-
nular region to increase coaptation surface of the cusps. One
late AV reoperation occurred in a patient who had under-
gone cusp repair for a type I valve with subcommissural
annuloplasty and presented 6.5 years later with recurrent
cusp prolapse and dilatation of the ventriculoaortic junction.
Surgical inspection revealed dilatation of the muscular
portion of the aortic annulus and migration of the subcom-
missural annuloplasty sutures and resulting prolapse of the
conjoint cusp. This reinforces the idea that the aortic annulus
in these patients can continue to dilate over time, and root re-
placement using the reimplantation technique should be
used aggressively to stabilize the repair.STUDY LIMITATIONS
This is a single-center experience using an approach and
surgical techniques that have evolved over the past decade.
In addition, follow-up echocardiographic information was
not always obtained at Saint Luc Hospital, and thus a number
of quantitative parameters (size of aortic annulus, root, and
aorta) and descriptive features of recurrent AI (quantity, jet
origin, and direction) were not systematically available
and may have provided greater insight into the mechanisms
of repair failures.CONCLUSIONS
Repair of the BAV needs to address the pathology of the
cusp and the functional aortic annulus and be tailored to the
specific anatomy of the valve. Repair of regurgitant bicuspid
valves is feasible and provides excellent freedom from
valve-related complications. Freedom from reoperation
and recurrent insufficiency are acceptable at midterm
follow-up. Longer follow-up studies are required to deter-
mine the role of repair in the treatment of BAV insufficiency
in young patients.References
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Dr Hartzell Schaff (Rochester, Minn). Congratulations to Drs
Boodhwani and El Khoury and their associates for a beautiful pre-
sentation, which is useful to us because it shows the spectrum of
operations in patients with BAV disease and is notable for the
very low mortality.
The problem with the article in regard to application to clinical
practice is that most patients with BAV disease present in 1 of 3
ways in terms of consideration of repair. Those are the patients
with severe AV regurgitation and indication for operation is severe
AR. Also, patients may have an enlarged aorta with only moderate
AR. And a few patients present with both. I think it is important toery c August 2010
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Dlook at the results of valve repair in each of those categories. So the
first question is, have you analyzed the outcome in regard to need
for reoperation according to the severity of the AV regurgitation?
Dr Boodhwani. That is a very important question, and we have
analyzed our data with regard to operative indication. I can show
you a slide with regard to this. Essentially, we did not find any dif-
ference among the 3 modes of presentation and the long-term out-
come with regard to recurrent AI or to AV reoperation, and we can
view that data here.
(Slide) This is freedom fromAV reoperation in patients who had
AI only, AI plus dilatation, or dilatation only, and there is really no
significant difference to speak of. Similarly, recurrent AI is similar
between groups as well.
Dr Schaff. And knowing that you have these good results with
repair of severe aortic regurgitation, has it changed your threshold
for advising operation as it has, for example, with mitral regurgita-
tion and the ability to repair the valve rather than replace it?
Dr Boodhwani. In fact, one of the common findings in the entire
cohort of AV repair that we have accumulated over the years is that
patients with greater dilatation of the left ventricular cavity have an
increased risk of recurrent AI. So the longer you wait in terms of
referring these patients to surgery, if they are to undergo repair,
they will have a poorer longer-term result with the repair, and
that may be an impetus to refer these patients for repair earlier. Hav-
ing said that, there aren’t convincing data in the literature to date to
make such a recommendation, but these are some of the data that
we are analyzing in our cohort.
Dr Schaff. One of the things that I noticed in your presentation
and article that differs from our experience is the frequency with
which you use aortic root replacement. We do see patients with di-
latation of the sinus portion of the aorta who have BAV, but, more
commonly, the patients at our clinic receive replacement of the as-
cending aorta with a supracoronary graft. What accounts for the
high frequency of replacement of the sinus portion of the aorta in
this series?
Dr Boodhwani. The first comment would be that this approach
has evolved over 13 years of experience, and over that time period
we have become more aggressive with root replacement, because
we have observed that patients in whom the aortic root is stabilized
with subcommissural annuloplasty alone tend to come back with
some AI over the long term. So our threshold has decreased over
time.
The second issue is that the criteria for root replacement, as you
mentioned, is not size alone. Often you find a root that is 4 cm in
size, but when you examine the aortic wall, particularly above
the anterior cusp below the right coronary artery insertion, it is
very fine. It can be occasionally translucent, and you can see the
left ventricular muscle through it, and in those cases we opt to
replace the root.
Dr Schaff. If you have a retracted cusp with scarring or enough
calcification that you have to use pericardium, would you do that
now or would you just replace the valve?
Dr Boodhwani. I think that has to take into account the broader
context of the patient. If the patient is very interested in avoiding
Coumadin and it is a young patient, we would be more aggressive
with repair techniques. On the other hand, if it is an older patient
who would be fine with a bioprosthetic valve, in those difficult
cases we may opt for replacement.The Journal of Thoracic and CaDr Jason Sperling (Ridgewood, NJ). Nothing to disclose.
Thank you for that fantastic presentation. I wanted to make a com-
parison and perhaps a suggestion. These results are fantastic, and I
hope we continue to build on them.
In mitral valve repair, when we do leaflet-based repairs, we still
do an annuloplasty to protect that repair in the future so that annular
changes don’t ruin the nice leaflet repair. You are doing these leaf-
let-based repairs with what you are calling a subcommissural annu-
loplasty, but perhaps a mechanism of failure is that your annulus,
your true annulus, the ventriculoaortic junction, is changing over
time, and we noticed that in AI annuli, these are usually pretty
big annuli to begin with and perhaps there is a predisposition for
further dilatation over time. Why not, just as in a valve-sparing
root type dissection, simply do a real aortic annuloplasty (which
is possible)? You just cut your Dacron graft, do it over a Hegar
dilator, and fix it in a particular configuration just like we do for
a mitral valve. Do you think that that might enhance the durability
of these repairs? Obviously, we want these repairs to be durable
over time.
Dr Boodhwani. That is a great question. That is something that
we have thought about a lot over the course of the years and over
the course of our experience. To be honest, there isn’t a particular
device or technique that has currently been described to facilitate
a complete annuloplasty of the ventriculoaortic junction. Effec-
tively, that is performed using the aortic root reimplantation proce-
dure, and that is part of the reason why we think we observed better
results in that cohort. Earlier in our experience, and even occasion-
ally now, we will use subcommissural annuloplasty with the same
purpose, to try and stabilize the ventriculoaortic junction, but these
are not as stable over time.
I think there is a need for developing a method for annuloplasty
of the ventriculoaortic junction without having to replace the entire
root. If you put a Dacron graft around the root and maintain the na-
tive root in place, you are potentially at risk for inducing more cusp
prolapse because of the extensive amount of tissue that is within
that Dacron graft.
Dr Sperling. I think it is possible to do an annuloplasty without
actually replacing the sinus tissue with and extensive surgical dis-
section of the root down to the ventriculo-annular junction, again,
just with a very small ring or a piece of Dacron over a dilator. I think
it is something to consider.
Dr Boodhwani. Again, the anatomic limitations that prevent us
are at the level of the membranous septum and the level of what
would normally be a left–right commissure. We don’t always dissect
all the way down to the level of the ventriculoaortic junction. To
place an annuloplasty device at that level, it may not be symmetric.
But I agree with you that this concept needs to be further developed.
Dr Antonio Laudito (Wichita, Kan). My question is regarding
the ascending aorta. You were talking about criteria of resection,
but at the end you didn’t really point out what size, considering
your large experience, you are pushing your replacement. We
know that with the bicuspid valve-ascending aorta, in case of dila-
tation, we are more aggressive than for the regular aneurysm. In
your experience, how far down in size have you been going?
Dr Boodhwani. If a patient is presenting for isolated aortic di-
latation, our threshold is still the that recommended by the Ameri-
can Heart Association and European Society of 5 cm, if that is the
only pathology they have. However, if the patients are presentingrdiovascular Surgery c Volume 140, Number 2 283
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Dwith AI and aortic dilatation, then there is the dual indication for re-
ferral to surgery. In those cases we are more aggressive. And, as I
mentioned in the algorithm, anyone above 4.5 will definitely get
a root replacement, whereas below 4.5, it is a judgment call based
on the quality of the tissue.
Dr Robert Dion (Genk, Belgium). I am proud of what my team
in Brussels has developed in this field. I have a short clinical com-
ment related to my initial experience. When you have a type I with
a common prolapsing leaflet, the first move would be to adapt this
prolapsing leaflet, with or without eliminating the raphe, to the
height of the other one. But I think we should reinforce the impor-
tance of first checking this other one, which should not be prolaps-
ing at all! How often does it happen in your experience that you
have to correct not only the obviously prolapsing one but also the284 The Journal of Thoracic and Cardiovascular Surgfalsely normal one? I think it is an important point for people start-
ing their experience in this field.
Dr Boodhwani. Excellent comment. In fact, an intervention on
the nonconjoint cusp is required in a good proportion of patients
(30%–40%), and the reason for that is 2-fold. One is that the non-
conjoint cusp may in fact be prolapsing in addition to the conjoint
cusp. Second, when you perform a root replacement procedure and
reduce the ventriculoaortic junction diameter, you may induce pro-
lapse of that leaflet. For both of those reasons, after any work has
been done on the raphe or root, we examine both leaflets to make
sure that the height of coaptation is at the midlevel of the sinuses
of Valsalva, which is the physiologic valve coaptation level, and
that both cusps are coapting at the same level, and those 2 are crit-
ical points for long-term function of this valve.ery c August 2010
FIGUREE1. Cusp repair techniques. A, To assess adequacy of cusp tissue in type 1 bicuspid valves, gentle traction is applied on a 6-0 polypropylene suture
that is passed on either side of the raphe´. After raphe´ resection, the edges may be directly reapproximated if adequate tissue is present (B) or a pericardial patch
is used for cusp restoration (C). D, Residual prolapse may be corrected by free margin resuspension using 7-0 polytetrafluoroethylene (white) suture.
TABLE E1. Early and late aortic valve reoperations
Year Interval Valve type
Aortic root
intervention Raphe´ repair
Other cusp repair
technique(s)
Failure
mode
Mechanism of
failure
Type of AV
reoperation
Early AV reoperations
1997 day 7 1 SCA Direct suture FMP AI Suture dehiscence Re-repair
1998 day 12 0 Remodeling; SCA — FMP AI Cusp prolapse Ross procedure
1998 day 6 0 SCA — Patch on perforation AI Coaptation defect Ross procedure
2006 day 10 1 SCA Shaving FMP; FMR Fistula Aorta–right ventricle
fistula
Re-repair
2008 day 6 1 SCA Shaving FMP; direct suture of
perforation
AI Suture dehiscence Re-repair
Late AV reoperations
1996 8 y 1 AA replacement Direct suture Decalcification AS Calcification Bioprosthesis
2000 7 y 1 SCA Shaving FMP; FMR AIþAS Cusp prolapse,
calcification
Bioprosthesis
2001 2 y 1 SCA Patch* — AI Cusp prolapse Ross procedure
2002 6 y 1 SCA Direct suture FMR AI Cusp prolapse (PTFE
rupture), calcification
Ross procedure
2002 6.5 y 0 Remodeling; SCA — FMP AI Endocarditis Re-repair
2002 6.5 y 1 SCA Direct suture FMR AI Cusp prolapse Re-repair
2007 2 y 0 SCA — FMP; FMR; patch on
perforation
AI Cusp prolapse Bioprosthesis
SCA, Subcommissural annuloplasty; AA, ascending aorta; AI, aortic insufficiency; AV, aortic valve; AS, aortic stenosis; PTFE, polytetrafluoroethylene; FMP, free margin plication;
FMR, free margin resuspension (with 7-0 PTFE). *Tricuspid valve autograft patch was used in this patient.
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